日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens

罗贝尼定类似物 NCL259 和 NCL265 对抗革兰氏阴性病原体的体外活性

Hongfei Pi, Henrietta Venter, Cecilia C Russell, Kelly A Young, Adam McCluskey, Stephen W Page, Abiodun D Ogunniyi, Darren J Trott

In vitro Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice

罗苯尼定类似物 NCL195 与外膜通透剂联合使用对革兰氏阴性细菌病原体的体外活性以及对小鼠全身革兰氏阳性细菌感染的影响

Hongfei Pi, Hang Thi Nguyen, Henrietta Venter, Alexandra R Boileau, Lucy Woolford, Sanjay Garg, Stephen W Page, Cecilia C Russell, Jennifer R Baker, Adam McCluskey, Lisa A O'Donovan, Darren J Trott, Abiodun D Ogunniyi

In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens

罗苯尼定、乙二胺四乙酸和多粘菌素B九肽对重要人类和兽医病原体的体外抗菌活性

Manouchehr Khazandi, Hongfei Pi, Wei Yee Chan, Abiodun David Ogunniyi, Jowenna Xiao Feng Sim, Henrietta Venter, Sanjay Garg, Stephen W Page, Peter B Hill, Adam McCluskey, Darren J Trott

Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent

评估罗贝尼定类似物 NCL195 作为新型广谱抗菌剂的效果

Abiodun D Ogunniyi, Manouchehr Khazandi, Andrew J Stevens, Sarah K Sims, Stephen W Page, Sanjay Garg, Henrietta Venter, Andrew Powell, Karen White, Kiro R Petrovski, Geraldine Laven-Law, Eliane G Tótoli, Hérida R Salgado, Hongfei Pi, Geoffrey W Coombs, Dean L Shinabarger, John D Turnidge, James C Pa